bg
G

Greenwich Lifesciences (GLSI)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD
barakagetbaraka.com

About Greenwich Lifesciences (GLSI)

Greenwich LifeSciences, Inc. is a clinical stage biopharmaceutical company. The Company is developing, GP2, a breast cancer immunotherapy focused on preventing the recurrence of breast cancer following surgery. GP2 is a nine amino acid transmembrane ... Read more

  • USD14.49
  • USD14.62
  • USD13.93
  • USD21.44
  • -18.80%
  • --
  • 35.83k
  • 36.24k
  • 169M
  • 7.58
  • 25.00%

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.